A detailed history of Rock Springs Capital Management LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 1,746,449 shares of APLT stock, worth $1.54 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
1,746,449
Previous 1,555,004 12.31%
Holding current value
$1.54 Million
Previous $7.26 Million 104.43%
% of portfolio
0.51%
Previous 0.23%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.35 - $8.5 $832,785 - $1.63 Million
191,445 Added 12.31%
1,746,449 $14.8 Million
Q2 2024

Aug 14, 2024

BUY
$4.04 - $6.37 $230,627 - $363,637
57,086 Added 3.81%
1,555,004 $7.26 Million
Q1 2024

May 15, 2024

BUY
$2.25 - $7.4 $1.36 Million - $4.46 Million
602,723 Added 67.33%
1,497,918 $10.2 Million
Q4 2023

Feb 14, 2024

BUY
$1.84 - $3.35 $158,950 - $289,393
86,386 Added 10.68%
895,195 $3 Million
Q3 2023

Nov 14, 2023

BUY
$1.26 - $2.77 $35,302 - $77,609
28,018 Added 3.59%
808,809 $2.01 Million
Q1 2023

May 15, 2023

BUY
$0.75 - $1.21 $138,083 - $222,774
184,111 Added 30.86%
780,791 $632,000
Q4 2022

Feb 14, 2023

SELL
$0.54 - $1.12 $56,700 - $117,600
-105,000 Reduced 14.96%
596,680 $453,000
Q1 2021

May 17, 2021

BUY
$16.57 - $28.65 $1.09 Million - $1.89 Million
65,843 Added 10.36%
701,680 $13.2 Million
Q4 2020

Feb 16, 2021

SELL
$15.44 - $24.23 $5.49 Million - $8.62 Million
-355,736 Reduced 35.88%
635,837 $14 Million
Q2 2020

Aug 14, 2020

BUY
$29.41 - $51.23 $4.29 Million - $7.47 Million
145,873 Added 17.25%
991,573 $35.8 Million
Q1 2020

May 15, 2020

BUY
$19.54 - $55.47 $16.1 Million - $45.8 Million
825,385 Added 4062.93%
845,700 $27.6 Million
Q4 2019

Feb 14, 2020

BUY
$10.16 - $28.14 $206,400 - $571,664
20,315 New
20,315 $554,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $42.3M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.